BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 16054641)

  • 1. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
    Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B.
    Albarran B; Goncalves L; Salmen S; Borges L; Fields H; Soyano A; Montes H; Berrueta L
    APMIS; 2005; 113(7-8):526-35. PubMed ID: 16086823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of human natural killer cells using a clinical-scale immunomagnetic method.
    Iyengar R; Handgretinger R; Babarin-Dorner A; Leimig T; Otto M; Geiger TL; Holladay MS; Houston J; Leung W
    Cytotherapy; 2003; 5(6):479-84. PubMed ID: 14660043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
    Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
    Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
    Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
    Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the zeta protein subunit in CD3- NK effectors derived from human thymus.
    Beecher MS; Baiocchi RA; Linett ML; Krajewski CA; Caligiuri MA
    Cell Immunol; 1994 May; 155(2):508-16. PubMed ID: 7514106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 is expressed in human natural killer cells and is regulated by interleukin-2.
    Jiang S; Munker R; Andreeff M
    Nat Immun; 1996-1997; 15(6):312-7. PubMed ID: 9523282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
    Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
    Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.